FDA Drug Recalls

Recalls / Class II

Class IID-0486-2020

Product

Grandall Oftal-Mycin Ophthalmic Ointment, Product Size: 3.5 g

Affected lot / code info
Lot #: QJD, Exp 10/19; RFK, Exp 6/20; SCB, Exp 3/21; TBI, Exp 2/22

Why it was recalled

Lack of Assurance of Sterility

Recalling firm

Firm
Altaire Pharmaceuticals, Inc.
Notification channel
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Type
Voluntary: Firm initiated
Address
311 W Ln, PO Box 849, Aquebogue, New York 11931-0849

Distribution

Quantity
N/A
Distribution pattern
U.S.A. Nationwide

Timeline

Recall initiated
2019-07-02
FDA classified
2019-11-15
Posted by FDA
2019-11-27
Status
Completed

Source: openFDA Drug Enforcement endpoint. Recall record D-0486-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls